Prevalence of the Brugada sign in idiopathic ventricular fibrillation and healthy controls

Heart

Volumn 84, Issue 1, 2000, Pages 31-36

  Viskin, S ^a   Fish, R ^a   Zeltser, D ^a   Glick, A ^a   Belhassen, B ^a   Eldar, M ^a   Lesh, M D ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Brugada syndrome; Cardiac arrest; Sudden death; Ventricular fibrillation

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BRUGADA SYNDROME; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROCARDIOGRAM; FEMALE; HEART RIGHT BUNDLE BRANCH BLOCK; HEART VENTRICLE FIBRILLATION; HUMAN; MALE; PREVALENCE; PRIORITY JOURNAL; ST SEGMENT ELEVATION;

EID: 0033936489     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.84.1.31     Document Type: Article

References (35)

1. Beihassen B, Shapira I, Shoshani D, et al. Idiopathic ventricular fibrillation: inducibility and beneficial effects of class I antiarrhythmic agents. Circulation 1987;75: 809-16.
2. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol 1992;20:1391-6.
3. Brugada J, Brugada P. Right bundle branch block and ST segment elevation in leads V1 through V3. A marker for sudden death in patients without demonstrable structural heart disease. Circulation 1998;97:457-60.
4. Gussak I, Antzelevitch C, Bjerregaard P, et al. The Brugada syndrome: clinical, electrophysiologic and genetic aspects. Circulation 1999;33:5-15.
5. Alings M, Wilde A. "Brugada" syndrome. Clinical data and suggested pathophysiological mechanism. Circulation 1999; 99:666-73.
6. Miyazaki T, Mitamura H, Miyoshi S, et al. Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome. J Am Coll Cardiol 1996;27:1061-70.
7. Scheinman M. Is the Brugada syndrome a distinct clinical entity? J Cardiovasc Electrophysiol 1997;8:332-6.
8. Viskin S, Belhassen B. Idiopathic ventricular fibrillation. Am Heart J 1990;120:661-71.
9. Viskin S, Belhassen B. Polymorphic ventricular tachyarrhythmias in the absence of organic heart disease. Classification, differential diagnosis and implications for therapy. Prog Cardiovasc Dis 1998;41:17-34.
10. Consensus Statement of the Joint Committees of the Unexplained Cardiac Arrest Registry of Europe and of the Idiopathic Ventricular Fibrillation Registry in the United States. Survivors of out-of-hospital cardiac arrest with apparently normal heart. Need for definition and standardized clinical evaluation. Circulation 1996;95:265-72.
11. Viskin S, Belhassen B. Clinical problem solving: when you only live twice. N Engl J Med 1995;332:1221-5.
12. Belhassen B, Pelleg A, Miller HI, et al. Serial electrophysiological studies in a young patient with recurrent ventricular fibrillation. PACE 1981;4:92-9.
13. Belhassen B, Viskin S. Idiopathic ventricular tachycardia and fibrillation. J Cardiovasc Electrophysiol 1993;4:356-68.
14. Belhassen B, Viskin S. Management of idiopathic ventricular fibrillation: implantable defibrillators? Antiarrhythmic drugs? ANE 1998;3:125-8.
15. Belhassen B, Viskin S, Fish R, et al. Effects of electrophysiologic-guided therapy with class 1A antiarrhythmic drugs on the long-term outcome of patients with idiopathic ventricular fibrillation with or without the Brugada syndrome. J Cardiovasc Electrophysiol 1999;10: 1301-12.
16. Brugada J, Brugada P. What to do in patients with no structural heart disease and sudden arrhythmic death? Am J Cardiol 1996;78(suppl 5A):69-75.
17. Viskin S, Lesh M, Eldar M, et al. Mode of onset of malignant ventricular arrhythmias in idiopathic ventricular fibrillation. J Cardiovasc Electrophysiol 1997;8: 1115-20.
18. Martini B, Nava A, Thiene C, et al. Ventricular fibrillation without apparent heart disease: description of six cases. Am Heart J 1989;118:1203-9.
19. Corrado D, Nava A, Buja G, et al. Familial cardiomyopathy underlies syndrome of right bundle branch block, ST segment elevation and sudden death. J Am Coll Cardiol 1996; 27:443-8.
20. Atarashi H, Ogawa S, Haruni K, et al. Characteristics of patients with right bundle branch block and ST-segment elevation in right precordial leads. Am J Cardiol 1996;78: 581-3.
21. Gussak I, Bjerregaard P, Egan TE, et al. ECG phenomenon called the J wave. History, pathophysiology and clinical significance. J Electrocardiol 1995;28:49-58.
22. Yan G, Antzelevitch C. Cellular basis for the electrocardiographic J wave. Circulation 1996;93:372-9.
23. Chen Q, Kirsch G, Zhang D, et al. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature 1998;392:293.
24. Nademanee K, Veerakul G, Nimmannit S, et al. Arrhythmogenic marker for the sudden unexpected death syndrome in Thai men. Circulation 1997;96:2595-600.
25. Kasanuki H, Ohnishi S, Ohtuka M, et al. Idiopathic ventricular fibrillation induced with vagal activity in patients without obvious heart disease. Circulation 1997;95: 2277-85.
26. Aponte G. The enigma of "Bangungut". Ann Intern Med 1960;52:1258-63.
27. Baron R, Thaker S, Gorelkin L, et al. Sudden death among Southeast Asian refugees. An unexplained nocturnal phenomenon. JAMA 1983;250:2947-51.
28. Wever EFD, Hauer RNW, Oomen A, et al. Unfavorable outcome in patients with primary electrical disease who survived an episode of ventricular fibrillation. Circulation 1993;88:1021-9.
29. Rook MB, Alshinawi C, Groenewegen WA, et al. Human SCN5A gene mutations alter Na-current kinetics and associate with VF in patients without structural heart disease [abstract]. Circulation 1998;98(suppl I):468.
30. Alshinawi C, Mannens M, Wilde A. Mutations in the human cardiac sodium channel gene (SCN5A) in patients with Brugada's syndrome [abstract]. Eur Heart J 1998; 19(suppl):78.
31. Roden DM, Wilde AAM. Drug-induced J-point elevation: a marker for genetic risk of sudden death or ECG curiosity? J Cardiovasc Electrophysiol 1999;10:219-23.
32. Fujiki A, Usui M, Nagasawa H, et al. ST segment elevation in the right precordial leads induced with class 1C antiarrhythmic drugs: insight into the mechanism of Brugada syndrome. J Cardiovasc Electrophysiol 1999;10:214-18.
33. Lemery R, Brugada P, Della Bella P, et al. Ventricular fibrillation in six adults without overt heart disease. J Am Coll Cardiol 1989;13:911-16.
34. Antzelevitch C. The Brugada syndrome. J Cardiovasc Electrophysiol 1998;9:513-16.
35. Brugada R, Brugada J, Antzelevitch C, et al. Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts. Circulation 2000;101: 510-15.